Developer docs
API playgroundTry for free, no card

Search company profiles

CMPI

Full company profile

uuid000jkqe

Namestring
CMPI
Legal namestring
Center for Medicine in the Public Interest
Websiteurl
cmpi.org
Company typeenum
Private
Founded yearint
2009
Descriptiontext

CMPI (Center for Medicine in the Public Interest) is a nonprofit, nonpartisan research and educational organization founded in 2009 in New York, focused on advancing patient-centered healthcare policy. Its mission is to promote medicine that is more preventive, predictive, and personalized, with a thematic focus on FDA regulation, drug pricing, pharmaceutical supply chains, hospital billing practices, and comparative effectiveness research. The organization produces policy reports, white papers, op-eds, and the Drugwonks blog, and convenes stakeholders through events such as the annual Odyssey Gala, Capitol Hill briefings, and topical summits (e.g., the 3D Printing Summit). It has a Paris office in addition to its New York headquarters, indicating some international reach.

CMPI does not develop or sell technology products; its "deliverables" are thought leadership content and event programming. The go-to-market model is event- and content-driven: it reaches policymakers, healthcare professionals, media, and patient advocates through earned media (CNBC, Fox Business, Bloomberg, CNN), social channels, congressional testimony, and direct briefings. Revenue comes from donations and corporate sponsorships drawn primarily from the pharmaceutical and biotechnology industries, including major donors such as AbbVie, Pfizer, Bristol Myers Squibb, Merck, Gilead Sciences, GSK, Novo Nordisk, PhRMA, BIO, and the Lilly Foundation. Leadership is anchored by co-founders Peter J. Pitts (President; former FDA Associate Commissioner) and Robert M. Goldberg (Vice President), supported by a Board of Directors and Senior Fellows drawn from academia, medicine, and policy.

Short descriptiontext

CMPI is a nonprofit, nonpartisan healthcare policy think tank founded in 2009 that produces research, commentary, and events to advance patient-centered medicine, funded primarily by pharmaceutical industry sponsors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare policy research, patient-centered medicine, pharmaceutical policy analysis, FDA regulatory commentary, healthcare reform advocacy
Industry1 code
PRIMARYMPAAADAD
Healthcare & Life Sciences PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies
Product category
Healthcare Policy Research
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Sponsorships
TypeSubscription Recurring
Description

CMPI is funded by donations and sponsorships from pharmaceutical companies, biotech firms, foundations, and other organizations in the healthcare sector. Major corporate sponsors include AbbVie, Pfizer, Bristol Myers Squibb, GSK, Gilead Sciences, Merck, Novo Nordisk, PhRMA, BIO, and others.

cmpi.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Center for Medicine in the Public Interest (CMPI) is a nonprofit, nonpartisan research and educational organization that produces healthcare policy research, white papers, reports, and educational events. It also maintains the Drugwonks blog, publishes commentary, hosts summits, galas and congressional briefings, and provides expert media commentary on FDA regulation, drug pricing, personalized medicine, biosimilars, and healthcare reform. CMPI does not sell commercial products; its offerings are research, educational content, and convening activities funded by donations and sponsorships.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Hundreds of published reports and articles on healthcare policy topics
+1 more record
Product overview1 text field

CMPI (Center for Medicine in the Public Interest) is a nonprofit, nonpartisan research and educational organization focused on healthcare policy research and advocacy, not a technology product company. It does not offer software products, platforms, or modules. Its outputs consist of policy research reports, commentary, events/conferences, videos, audio content, and educational resources on healthcare topics including FDA policy, drug pricing, personalized medicine, and hospital billing reform.

Product and service5 records
1Critical Path Project
CategoryHealthcare Policy Research
Description

CMPI initiative conducted in cooperation with the Critical Path Institute to advance drug safety and regulatory science. It targets healthcare policy stakeholders, regulators, and pharmaceutical industry participants engaged in FDA regulatory science.

2Patient-Centric Prospective Medicine Project
CategoryHealthcare Policy Research
Description

CMPI research program on patient-centric, prospective, and personalized medicine, with prior collaboration with Intermune on idiopathic pulmonary fibrosis research. It is intended for healthcare professionals, patient advocates, and policy researchers.

3Drugwonks Blog
CategoryPolicy Commentary and Media
Description

Editorial blog providing commentary on the pharmaceutical industry, FDA policy, drug pricing, PBMs, and healthcare reform. Targeted at healthcare professionals, policymakers, journalists, and the informed public.

4Policy Events and Convenings (Odyssey Gala, 3D Printing Summit, Capitol Hill Briefings)
CategoryEducational Events
Description

Educational and policy convenings including the annual Odyssey Gala honoring healthcare leaders, the 3D Printing Summit, Capitol Hill Briefings, and policy forums. Designed for policymakers, healthcare professionals, and industry stakeholders.

5Policy Research Reports and White Papers
CategoryHealthcare Policy Research
Description

Published research reports, white papers, and policy analysis on healthcare topics including FDA regulation, drug pricing, hospital billing practices, biosimilars, and pharmaceutical supply chain policy. Targeted at policymakers, regulators, media, and healthcare professionals.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CMPI cooperates with the Critical Path Institute on activities advancing the Critical Path Initiative for drug safety and regulatory science.

2Intermune
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Biotechnology company that supported CMPI's Patient-Centric and Prospective Medicine Project research program on idiopathic pulmonary fibrosis.

cmpi.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. John F P Bridges, Associate Professor at Johns Hopkins, serves as principal investigator and Senior Fellow at CMPI.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1American Enterprise Institute (AEI)
TypeBroad incumbent
Description

Large established think tank with a significant health policy program covering FDA, drug pricing, and healthcare reform. Operates as a broader institution but competes in the same healthcare commentary space as CMPI.

TypeBroad incumbent
Description

Major policy research institution with an extensive health policy center producing research and hosting events on FDA, drug pricing, and healthcare reform — adjacent to CMPI's policy commentary work.

TypeDirect peer
Description

A leading nonprofit health policy research organization producing analysis, polling, and journalism on healthcare, mirroring CMPI's role as a nonpartisan policy research voice serving policymakers and the public.

TypeDirect peer
Description

Policy think tank where co-founder Robert M. Goldberg previously led the Center for Medical Progress. Comparable to CMPI as a center-right policy shop with active healthcare and pharmaceutical policy work.

TypeOthers
Description

Major pharmaceutical industry trade association and CMPI donor. Comparable as a healthcare policy stakeholder, though PhRMA is an industry advocacy body rather than an independent think tank; useful benchmark for industry-aligned policy positioning.

TypeDirect peer
Description

Nonprofit health policy research organization focused on personalized medicine, patient-centered care, and biomedical innovation — overlapping thematically with CMPI's preventive, predictive, and personalized medicine focus.

TypeDirect peer
Description

Free-market policy think tank with a long-standing focus on healthcare, pharmaceuticals, and FDA policy; directly comparable to CMPI in mission, ideological orientation, and donor-supported research model.

TypeDirect peer
Description

Private foundation focused on healthcare policy research and promoting a high-performing healthcare system; comparable to CMPI in mission, donor-funded model, and policy analysis output.

TypeBroad incumbent
Description

Nonprofit economic think tank whose FasterCures and health programs publish widely on biomedical innovation, drug pricing, and public health — overlapping with CMPI's research and convening activities.

TypeBroad incumbent
Description

Stanford-based public policy research center with health policy work on FDA, drug development, and healthcare reform. Operates at a larger scale but addresses many of the same policy topics as CMPI.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CMPI

Healthcare Policy Researchcmpi.org

CMPI is a nonprofit, nonpartisan healthcare policy think tank founded in 2009 that produces research, commentary, and events to advance patient-centered medicine, funded primarily by pharmaceutical industry sponsors.

What CMPI does

CMPI (Center for Medicine in the Public Interest) is a nonprofit, nonpartisan research and educational organization founded in 2009 in New York, focused on advancing patient-centered healthcare policy. Its mission is to promote medicine that is more preventive, predictive, and personalized, with a thematic focus on FDA regulation, drug pricing, pharmaceutical supply chains, hospital billing practices, and comparative effectiveness research. The organization produces policy reports, white papers, op-eds, and the Drugwonks blog, and convenes stakeholders through events such as the annual Odyssey Gala, Capitol Hill briefings, and topical summits (e.g., the 3D Printing Summit). It has a Paris office in addition to its New York headquarters, indicating some international reach.

CMPI does not develop or sell technology products; its "deliverables" are thought leadership content and event programming. The go-to-market model is event- and content-driven: it reaches policymakers, healthcare professionals, media, and patient advocates through earned media (CNBC, Fox Business, Bloomberg, CNN), social channels, congressional testimony, and direct briefings. Revenue comes from donations and corporate sponsorships drawn primarily from the pharmaceutical and biotechnology industries, including major donors such as AbbVie, Pfizer, Bristol Myers Squibb, Merck, Gilead Sciences, GSK, Novo Nordisk, PhRMA, BIO, and the Lilly Foundation. Leadership is anchored by co-founders Peter J. Pitts (President; former FDA Associate Commissioner) and Robert M. Goldberg (Vice President), supported by a Board of Directors and Senior Fellows drawn from academia, medicine, and policy.

CMPI firmographics

Firmographics
Name
CMPI
Legal name
Center for Medicine in the Public Interest
Website
https://cmpi.org
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
1–10 employees
Short description
CMPI is a nonprofit, nonpartisan healthcare policy think tank founded in 2009 that produces research, commentary, and events to advance patient-centered medicine, funded primarily by pharmaceutical industry sponsors.
Ownership category
akta.pro rank

CMPI industry classification

Industry
Product category
Healthcare Policy Research
akta.pro industry
PRIMARYMPAAADAD
Healthcare & Life Sciences PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies

Keywords

  • Healthcare policy research
  • Patient-centered medicine
  • Pharmaceutical policy analysis
  • FDA regulatory commentary
  • Healthcare reform advocacy

Where CMPI is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices3 records

Markets served

CMPI business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Donations and Sponsorships: CMPI is funded by donations and sponsorships from pharmaceutical companies, biotech firms, foundations, and other organizations in the healthcare sector. Major corporate sponsors include AbbVie, Pfizer, Bristol Myers Squibb, GSK, Gilead Sciences, Merck, Novo Nordisk, PhRMA, BIO, and others.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

CMPI product offering

Product offering

Core offering

The Center for Medicine in the Public Interest (CMPI) is a nonprofit, nonpartisan research and educational organization that produces healthcare policy research, white papers, reports, and educational events. It also maintains the Drugwonks blog, publishes commentary, hosts summits, galas and congressional briefings, and provides expert media commentary on FDA regulation, drug pricing, personalized medicine, biosimilars, and healthcare reform. CMPI does not sell commercial products; its offerings are research, educational content, and convening activities funded by donations and sponsorships.

Product overview

CMPI (Center for Medicine in the Public Interest) is a nonprofit, nonpartisan research and educational organization focused on healthcare policy research and advocacy, not a technology product company. It does not offer software products, platforms, or modules. Its outputs consist of policy research reports, commentary, events/conferences, videos, audio content, and educational resources on healthcare topics including FDA policy, drug pricing, personalized medicine, and hospital billing reform.

Differentiator

Problem solved

Functional benefit

Products and services

  • Critical Path Project CMPI initiative conducted in cooperation with the Critical Path Institute to advance drug safety and regulatory science. It targets healthcare policy stakeholders, regulators, and pharmaceutical industry participants engaged in FDA regulatory science.
  • Patient-Centric Prospective Medicine Project CMPI research program on patient-centric, prospective, and personalized medicine, with prior collaboration with Intermune on idiopathic pulmonary fibrosis research. It is intended for healthcare professionals, patient advocates, and policy researchers.
  • Drugwonks Blog Editorial blog providing commentary on the pharmaceutical industry, FDA policy, drug pricing, PBMs, and healthcare reform. Targeted at healthcare professionals, policymakers, journalists, and the informed public.
  • Policy Events and Convenings (Odyssey Gala, 3D Printing Summit, Capitol Hill Briefings) Educational and policy convenings including the annual Odyssey Gala honoring healthcare leaders, the 3D Printing Summit, Capitol Hill Briefings, and policy forums. Designed for policymakers, healthcare professionals, and industry stakeholders.
  • Policy Research Reports and White Papers Published research reports, white papers, and policy analysis on healthcare topics including FDA regulation, drug pricing, hospital billing practices, biosimilars, and pharmaceutical supply chain policy. Targeted at policymakers, regulators, media, and healthcare professionals.

Quantifiable outcome

  • Hundreds of published reports and articles on healthcare policy topics
  • +1 more outcomes

Companies that use CMPI

Customer profile

Segments4 records

Ideal customer profiles4 records

CMPI technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

CMPI partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Critical Path InstitutecoreStrategic or Co-development PartnerCMPI cooperates with the Critical Path Institute on activities advancing the Critical Path Initiative for drug safety and regulatory science.
  • IntermunecoreStrategic or Co-development PartnerBiotechnology company that supported CMPI's Patient-Centric and Prospective Medicine Project research program on idiopathic pulmonary fibrosis.
  • Johns Hopkins Bloomberg School of Public HealthcoreStrategic or Co-development PartnerDr. John F P Bridges, Associate Professor at Johns Hopkins, serves as principal investigator and Senior Fellow at CMPI.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

CMPI competitors and assessment

Company assessment

Broad incumbents

  • American Enterprise Institute (AEI): Large established think tank with a significant health policy program covering FDA, drug pricing, and healthcare reform. Operates as a broader institution but competes in the same healthcare commentary space as CMPI.
  • Brookings Institution: Major policy research institution with an extensive health policy center producing research and hosting events on FDA, drug pricing, and healthcare reform — adjacent to CMPI's policy commentary work.
  • Milken Institute: Nonprofit economic think tank whose FasterCures and health programs publish widely on biomedical innovation, drug pricing, and public health — overlapping with CMPI's research and convening activities.
  • Hoover Institution: Stanford-based public policy research center with health policy work on FDA, drug development, and healthcare reform. Operates at a larger scale but addresses many of the same policy topics as CMPI.

Direct peers

  • Kaiser Family Foundation (KFF): A leading nonprofit health policy research organization producing analysis, polling, and journalism on healthcare, mirroring CMPI's role as a nonpartisan policy research voice serving policymakers and the public.
  • Manhattan Institute: Policy think tank where co-founder Robert M. Goldberg previously led the Center for Medical Progress. Comparable to CMPI as a center-right policy shop with active healthcare and pharmaceutical policy work.
  • Galen Institute: Nonprofit health policy research organization focused on personalized medicine, patient-centered care, and biomedical innovation — overlapping thematically with CMPI's preventive, predictive, and personalized medicine focus.
  • Pacific Research Institute: Free-market policy think tank with a long-standing focus on healthcare, pharmaceuticals, and FDA policy; directly comparable to CMPI in mission, ideological orientation, and donor-supported research model.
  • The Commonwealth Fund: Private foundation focused on healthcare policy research and promoting a high-performing healthcare system; comparable to CMPI in mission, donor-funded model, and policy analysis output.

Others

  • PhRMA (Pharmaceutical Research and Manufacturers of America): Major pharmaceutical industry trade association and CMPI donor. Comparable as a healthcare policy stakeholder, though PhRMA is an industry advocacy body rather than an independent think tank; useful benchmark for industry-aligned policy positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

CMPI social profiles

Digital presence

CMPI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CMPI leadership team

Management profile

Number of profiles

Profiles6 records

CMPI funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CMPI M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CMPI

What does CMPI do?

The Center for Medicine in the Public Interest (CMPI) is a nonprofit, nonpartisan research and educational organization that produces healthcare policy research, white papers, reports, and educational events. It also maintains the Drugwonks blog, publishes commentary, hosts summits, galas and congressional briefings, and provides expert media commentary on FDA regulation, drug pricing, personalized medicine, biosimilars, and healthcare reform. CMPI does not sell commercial products; its offerings are research, educational content, and convening activities funded by donations and sponsorships.

Is CMPI a public or private company?

CMPI is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was CMPI founded?

CMPI was founded in 2009. It employs 1 to 10 people.

Where is CMPI based?

CMPI is headquartered in New York, United States, in the North America region.

How does CMPI make money?

One revenue line is on record: donations and Sponsorships.

Who are CMPI's main competitors?

Broad incumbents on record are American Enterprise Institute (AEI), Brookings Institution, Milken Institute and Hoover Institution. Direct peers are Kaiser Family Foundation (KFF), Manhattan Institute, Galen Institute, Pacific Research Institute and The Commonwealth Fund. PhRMA (Pharmaceutical Research and Manufacturers of America) is listed as an others.

Does CMPI have an API?

No public API is recorded for CMPI.

What industry is CMPI in?

CMPI's product category is Healthcare Policy Research. Its primary akta.pro industry code is MPAAADAD, Healthcare & Life Sciences PR.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales